Literature DB >> 19352120

Neutrophilic tubulitis as a marker for urinary tract infection in renal allograft biopsies with C4d deposition.

Gaurav Gupta1, Ron Shapiro, Alin Girnita, Ibrahim Batal, Jerry McCauley, Amit Basu, Henkie Tan, Parmjeet Randhawa.   

Abstract

BACKGROUND: Neutrophilic tubulitis accompanied by intratubular neutrophil clusters in the renal allograft is a surrogate marker for urinary tract infection (UTI). Overlapping histologic findings can occur in antibody-mediated rejection, which is characterized by peritubular capillary (PTC) deposition of C4d. This study evaluated the incidence of UTI in biopsies with concurrent neutrophilic tubulitis and PTC C4d staining.
METHODS: Thirty-three allograft biopsies from 27 patients selected for the presence of simultaneous C4d staining and neutrophilic tubulitis were correlated with urine culture (U/C) results.
RESULTS: U/C obtained on the same day as the biopsy confirmed UTI in 13 of 33 (39%) biopsies. Among 20 patients with negative U/C; prior culture results within 10 days of the biopsy were available for nine patients, and 5 of 9 (55%) were positive. Thus, UTI was confirmed in 18 of 33 (54%) biopsies. Biopsy interpretation and clinical management was confounded by changes of concurrent acute cellular rejection and antibody-mediated rejection confirmed by demonstration of donor-specific antibodies. Combined therapy with antibiotics and antirejection medications (ART) was administered to 12 of 18 (67%) patients.
CONCLUSIONS: Neutrophilic tubulitis accompanied by neutrophil clusters in the tubular lumen is a useful marker of UTI, even in the presence of PTC C4d deposition. Therapeutic response to antibiotics is limited by co-existent T-cell or antibody-mediated rejection and underlying chronic allograft nephropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352120     DOI: 10.1097/TP.0b013e31819ca304

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Differential gene expression pattern in biopsies with renal allograft pyelonephritis and allograft rejection.

Authors:  Steve Oghumu; Uday Nori; Anna Bracewell; Jianying Zhang; Cherri Bott; Gyongyi M Nadasdy; Sergey V Brodsky; Ronald Pelletier; Abhay R Satoskar; Tibor Nadasdy; Anjali A Satoskar
Journal:  Clin Transplant       Date:  2016-08-08       Impact factor: 2.863

2.  Gram-negative sepsis following biopsy of a transplant recipient with asymptomatic allograft pyelonephritis.

Authors:  Hassan Al-Khayyat; Nigel Toussaint; Steve Holt; Peter Hughes
Journal:  CEN Case Rep       Date:  2016-11-04

3.  Acute pyelonephritis in renal allografts: a new role for microRNAs?

Authors:  Steve Oghumu; Anna Bracewell; Uday Nori; Kirsteen H Maclean; Joan-Miquel Balada-Lasat; Sergey Brodsky; Ronald Pelletier; Mitchell Henry; Abhay R Satoskar; Tibor Nadasdy; Anjali A Satoskar
Journal:  Transplantation       Date:  2014-03-15       Impact factor: 4.939

4.  Renal outcome in biopsy proven cases of graft pyelonephritis.

Authors:  P P Varma; A Jairam; A K Hooda; S Badwal
Journal:  Indian J Nephrol       Date:  2014-05

5.  Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates.

Authors:  Alin L Girnita; Lin Wang; Adriana I Colovai; Patrick Ahearn; Yorg Azzi; Madhav C Menon; Marcelo Fernandez-Vina; Howard M Gebel; E Steve Woodle; Paolo Cravedi; Jonathan S Maltzman; Enver Akalin
Journal:  Transplantation       Date:  2022-09-02       Impact factor: 5.385

6.  Antinatriuretic phenomena seen in children with acute pyelonephritis may be related to the activation of intrarenal RAAS.

Authors:  Jun Ho Lee; Su Jin Jang; Seonkyeong Rhie
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.